Obstructive sleep apnea: A cardiopulmonary perspective and medical therapeutics

American Journal of Therapeutics

Volumn 16, Issue 3, 2009, Pages 257-263

  Jalandhara, Nishant B ^a   Patel, Anil ^b   Arora, Rohit R ^a,c   Jalandhara, Priyanka ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Faxton St Luke's Healthcare   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Continuous positive airway pressure; Hypertension; Left ventricular ejection fraction; Left ventricular hypertrophy; Obstructive sleep apnea; Pulmonary hypertension

Indexed keywords

ACETAZOLAMIDE; ANTIHISTAMINIC AGENT; MEDROXYPROGESTERONE; PROTRIPTYLINE; THEOPHYLLINE; THYROXINE; TRYPTOPHAN;

CLINICAL FEATURE; DRUG MECHANISM; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; NONHUMAN; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP DISORDER; TONSILLECTOMY; TRACHEOTOMY; UVULOPALATOPHARYNGOPLASTY;

ACETAZOLAMIDE; CONTINUOUS POSITIVE AIRWAY PRESSURE; HEART VENTRICLES; HUMANS; LIFE STYLE; PSYCHOTROPIC DRUGS; SLEEP APNEA, OBSTRUCTIVE; THEOPHYLLINE; THYROXINE;

EID: 67249147745     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181788cdf     Document Type: Review

References (50)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235. (Pubitemid 23115702)
2. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22:667-689.
3. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Practice parameters for the indications for polysomnography and related procedures. Sleep. 1997;20:406-422.
4. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944. Am J Respir Crit Care Med. 1994;150:1738-1745.
5. National Commission on Sleep Disorders Research. Wake Up America: A National Sleep Alert. Vol 1. National Commission on Sleep Disorders Research; 1993.
6. National Commission on Sleep Disorders Research. Wake Up America: A National Sleep Alert. Vol 2. National Commission on Sleep Disorders Research; 1994.
7. Alderman MH. JNC 7: brief summary and critique. Clin Exp Hypertens. 2004;26:753-761. (Pubitemid 40129765)
8. Levinson PD, McGarvey ST, Carlisle CC, et al. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest. 1993;103:1336-1342. (Pubitemid 23145581)
9. Ancoli-Israel S, Coy T. Are breathing disturbances in elderly equivalent to sleep apnea syndrome? Sleep. 1994;17:77-83. (Pubitemid 24103644)
10. Weitzman ED. The syndrome of hypersomnia and sleep-induced apnea. Chest. 1979;75:414-415.
11. Noonan AJ. Reversible cor pulmonale due to hypertrophied tonsils and adenoids: studies in two cases [abstract]. Circulation. 1965;32(Suppl 2):164.
12. Moldofsky H. Evaluation of daytime sleepiness. Clin Chest Med. 1992;13:417-425.
13. Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis. 1988;138:337-340. (Pubitemid 18201892)
14. Hudgel DW. Mechanisms of obstructive sleep apnea. Chest. 1992;101:541-549.
15. Sullivan CE, Issa FG. Obstructive sleep apnea. Clin Chest Med. 1985;6:633-650. (Pubitemid 16175013)
16. Bonsignore MR, Marrone O, Insalaco G, et al. The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. Eur Respir J. 1994;7:786-805. (Pubitemid 24122978)
17. Harris P, Heath D. The HumanPulmonary Circulation. New York: Churchill Livingstone; 1986:702.
18. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983;52:490.
19. Burrek B. The hypersomnia-sleep apnea syndrome: its recognition in clinical cardiology. Am Heart J. 1984;107:543.
20. Bradley TD, Rutherford R, Grossman RF, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis. 1985;131:835-839. (Pubitemid 15065911)
21. Berman EJ, DiBenedetto RJ, Causey DE, et al. Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. Chest. 1991;100:347-350.
22. Guidry UC, Mendes LA, Evans JC, et al. Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart Study. Am J Respir Crit Care Med. 2001;164:933-938. (Pubitemid 32971635)
23. Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353:2025-2033. (Pubitemid 41609095)
24. Atwood CW Jr, McCrory D, Garcia JG, et al. Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(Suppl 1):72S-77S. (Pubitemid 38932343)
25. Fletcher EC, Schaaf JW, Miller J, et al. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis. 1987;135:525-533. (Pubitemid 17041577)
26. Kountz WB, Alexander H, Prinzmetal M. The heart in emphysema. Am Heart J. 1936;11:163-172.
27. Dursunoglu D, Dursunoglu N. Cardiovascular diseases in obstructive sleep apnea. Tuberk Toraks. 2006;54:382-396. (Pubitemid 351837750)
28. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034-2041. (Pubitemid 41609096)
29. Munoz R, Duran-Cantolla J, Martinez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke. 2006;37:2317-2321. (Pubitemid 44337176)
30. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625-1631. (Pubitemid 46551635)
31. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233-1241. (Pubitemid 36359299)
32. Fung JW, Li TS, Choy DK, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest. 2002;121:422-429. (Pubitemid 34132978)
33. Nahmias J, Lao R, Karetzky M. Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure. Eur Respir J. 1996;9:945-951. (Pubitemid 26191639)
34. Dursunoglu N, Dursunoglu D, Ozkurt S, et al. Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension. Respir Res. 2006;7:22. (Pubitemid 43286421)
35. Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med. 1996;335:562-567. (Pubitemid 26272311)
36. Mulloy E, McNicholas WT. Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest. 1992;101:753-757.
37. Tojima H, Kunitomo F, Kimura H, et al. Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax. 1988;43:113-119. (Pubitemid 18045557)
38. Whyte KF, Gould GA, Airlie MA, et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep. 1988;11:463-472. (Pubitemid 18229809)
39. Sharp JT, Druz WS, D'Souza V, et al. Effect of metabolic acidosis upon sleep apnea. Chest. 1985;87:619-624. (Pubitemid 15092115)
40. Cook WR, Benich JJ, Wooten SA. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest. 1989;96:262-266. (Pubitemid 19199532)
41. Block AJ, Wynne JW, Boysen PG, et al. Menopause, medroxyprogesterone and breathing during sleep. Am J Med. 1981;70:506-510. (Pubitemid 11153957)
42. Rajagopal KR, Abbrecht PH, Derderian SS, et al. Obstructive sleep apnea in hypothyroidism. Ann Intern Med. 1984;101:491-494. (Pubitemid 14018045)
43. Schmidt HS. L-tryptophan in the treatment of impaired respiration in sleep. Bull Eur Physiopathol Respir. 1983;19:625-629. (Pubitemid 14223649)
44. Sanders MH, Moore SE, Eveslage J. CPAP via nasal mask: a treatment for occlusive sleep apnea. Chest. 1983;83:144-145. (Pubitemid 13172771)
45. Mulgrew AT, Fox N, Ayas NT, et al. Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study. Ann Intern Med. 2007;146:157-166. (Pubitemid 351650628)
46. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999;353:2100-2105. (Pubitemid 29278478)
47. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359:204-210. (Pubitemid 34113817)
48. Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165:152-158. (Pubitemid 34084449)
49. Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N, et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest. 2005;128:624-633. (Pubitemid 41140489)
50. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29:375-380. (Pubitemid 44019961)